12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Gene and Cell Therapy”
![](https://pub.mdpi-res.com/announcement/6848.jpg?1724941758)
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment”
by Lu Tang, Shun He, Yue Yin, Hening Liu, Jingyi Hu, Jie Cheng and Wei Wang
Pharmaceutics 2021, 13(11), 1888; https://doi.org/10.3390/pharmaceutics13111888
Available online: https://www.mdpi.com/1999-4923/13/11/1888
2. “Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues”
by Elena Munoz-Perez, Ainhoa Gonzalez-Pujana, Manoli Igartua, Edorta Santos-Vizcaino and Rosa Maria Hernandez
Pharmaceutics 2021, 13(11), 1802; https://doi.org/10.3390/pharmaceutics13111802
Available online: https://www.mdpi.com/1999-4923/13/11/1802
3. “Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery”
by Magdalena M. Żak and Lior Zangi
Pharmaceutics 2021, 13(10), 1675; https://doi.org/10.3390/pharmaceutics13101675
Available online: https://www.mdpi.com/1999-4923/13/10/1675
4. “Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia”
by Patrick Connerty, Ernest Moles, Charles E. de Bock, Nisitha Jayatilleke, Jenny L. Smith, Soheil Meshinchi, Chelsea Mayoh, Maria Kavallaris and Richard B. Lock
Pharmaceutics 2021, 13(10), 1681; https://doi.org/10.3390/pharmaceutics13101681
Available online: https://www.mdpi.com/1999-4923/13/10/1681
5. “B3Pred: A Random-Forest-Based Method for Predicting and Designing Blood–Brain Barrier Penetrating Peptides”
by Vinod Kumar, Sumeet Patiyal, Anjali Dhall, Neelam Sharma and Gajendra Pal Singh Raghava
Pharmaceutics 2021, 13(8), 1237; https://doi.org/10.3390/pharmaceutics13081237
Available online: https://www.mdpi.com/1999-4923/13/8/1237
6. “Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment”
by Dima Hattab, Amirah Mohd Gazzali and Athirah Bakhtiar
Pharmaceutics 2021, 13(7), 1009; https://doi.org/10.3390/pharmaceutics13071009
Available online: https://www.mdpi.com/1999-4923/13/7/1009
7. “Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines”
by Saed Abbasi and Satoshi Uchida
Pharmaceutics 2021, 13(5), 644; https://doi.org/10.3390/pharmaceutics13050644
Available online: https://www.mdpi.com/1999-4923/13/5/644
8. “Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro”
by Dhireshan Singh and Moganavelli Singh
Pharmaceutics 2021, 13(3), 298; https://doi.org/10.3390/pharmaceutics13030298
Available online: https://www.mdpi.com/1999-4923/13/3/298
You can check all publications in the Section “Gene and Cell Therapy” at the following link: https://www.mdpi.com/search?journal=pharmaceutics§ion=1033.